Biopharmaceuticals Related Topics 
Frost & Sullivan
MAY 12, 2021
May 12, 2021 – The biopharmaceutical industry is facing its biggest test in recent times. Biopharmaceutical companies must follow suit by adopting advanced manufacturing technologies, establishing public-private partnerships and placing sustainability at the core of the business strategy.
McKinsey & Company
OCTOBER 27, 2022
The biopharmaceutical industry has made remarkable achievements in the past decade, but is it equipped to leap still further ahead in the coming one?
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Frost & Sullivan
JULY 22, 2021
As a result, academic labs and small biotech companies are accelerating RNA therapeutics research, alongside Tier 1 biopharmaceutical companies.”
Frost & Sullivan
AUGUST 9, 2021
Healthcare News Press Releases alliances biopharma biopharmaceutical Digital Health digital therapeutics Life Sciences medical device Medical Device Industry partner partnership pharma Pharmaceutical therapeutics
Frost & Sullivan
MARCH 30, 2021
Healthcare News Press Releases artificial intelligence biopharmaceuticals biotechnology diagnostics Digital Health Pharmaceutical telehealth Virtual Care
Frost & Sullivan
AUGUST 9, 2021
Healthcare News Press Releases Uncategorized alliances biopharma biopharmaceutical Digital Health digital therapeutics Life Sciences medical device Medical Device Industry partner partnership pharma Pharmaceutical therapeutics
McKinsey & Company
FEBRUARY 12, 2021
Increasingly, small biopharmaceutical companies are launching their new drugs themselves rather than relying on large pharma companies to do it for them.
McKinsey & Company
SEPTEMBER 20, 2021
Angela Hwang, Pfizer’s head of biopharmaceuticals, talks about breaking new ground when the pressure is on—and how having a deep company heritage can help. Insights on Life Sciences Pharmaceuticals Public health
Frost & Sullivan
MARCH 30, 2021
Healthcare News Press Releases Uncategorized artificial intelligence biopharmaceuticals biotechnology diagnostics Digital Health Pharmaceutical telehealth Virtual Care
ISTO / IEEE
NOVEMBER 3, 2022
IEEE-ISTO looks forward to supporting the important work of the Consortium’s mission to transform the biopharmaceutical QA process.”
Frost & Sullivan
OCTOBER 14, 2022
Parexel combines in-house expertise, patient and caregiver insights, and cutting-edge technologies to plan, operationalize, and deliver DCTs for biopharmaceutical customers worldwide while ensuring the highest levels of patient safety. SAN ANTONIO, TX. –
LaVoie Health Science Blog
OCTOBER 5, 2020
Strong detail oriented public relations/communications professional needed for growing life science/biopharmaceutical practice. Join a health science focused integrated communications agency and be part of the agency’s second phase of growth.
Frost & Sullivan
NOVEMBER 29, 2022
Automated processes, remote monitoring, and digital supply chains accelerate biomanufacturing rates of biopharmaceuticals.”. San Antonio –Nov. 29, 2022– The biomanufacturing sector is experiencing a digitalization transformation that is aligned with Industry 4.0.
Frost & Sullivan
JULY 19, 2021
Leveraging a leading suite of end-to-end biopharmaceutical development services covering patient-focused clinical trial design and decentralized clinical trial (DCT) strategies, the company has helped develop 198 of the 200 top-selling biopharmaceuticals in the market.
INSEAD Knowledge
DECEMBER 4, 2022
Bad for business The negative effect of peer competition on firm performance has previously been documented in the biopharmaceutical industry and the medical device industry. Firms working on new ideas often collaborate with partners to access complementary resources.
LaVoie Health Science Blog
NOVEMBER 12, 2020
In his new role, Heins will provide senior level communications counsel to LHS’s growing roster of biopharmaceutical, medical technology, health IT, and health care services clients. BOSTON & NEW YORK– NOVEMBER 12, 2020.
Frost & Sullivan
MAY 16, 2022
It offers novel precision health and wellness software-as-a-service (SaaS) solutions to patients, healthcare providers (HCPs), employers, health plans, and biopharmaceuticals.
Frost & Sullivan
JUNE 22, 2021
Invest in Blood Transfusion and Apheresis Membranes to Accelerate Revenue Growth : The increasing demand for blood plasma to create plasma-derived biopharmaceutical products will drive the demand for apheresis and transfusion membranes.
Phoenix Consulting Group
JUNE 9, 2020
Published by TIDWIT Inc. at June 2, 2020. An interview with Norma Watenpaugh, CEO & Founding Principal, Phoenix Consulting Group. Q: You have been involved with the channel and emerging ecosystems for some time. How has the concept of partnership evolved over the past several years?
Frost & Sullivan
DECEMBER 16, 2020
Furthermore, LabCorp Drug Development draws on its deep expertise in antiviral drugs and vaccines, as well as partners with biopharmaceutical companies to develop treatment and vaccines for COVID-19 through improved detection methods.”
Frost & Sullivan
APRIL 11, 2022
The platform allows faster and more cost-effective development of new biopharmaceuticals.
Expert insights. Personalized for you.
52 
Let's personalize your content